<< Back |
Stereotaxis Elects Medical Device Industry Veteran Duane DeSisto to Board of Directors
|
"Duane brings more than 25 years of experience in the medical device industry and is a visionary business leader with a highly successful track record of driving and managing transformational growth in startup and public companies," said
Mr. DeSisto served as President and CEO of
"
About
The core components of
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, the Company's ability to raise additional capital on a timely basis and on terms that are acceptable, its ability to continue to manage expenses and cash burn rate at sustainable levels, its ability to continue to work with lenders to extend, repay or refinance indebtedness on acceptable terms, continued acceptance of the Company's products in the marketplace, the effect of global economic conditions on the ability and willingness of customers to purchase its systems and the timing of such purchases, competitive factors, changes resulting from the recently enacted healthcare reform in the U.S., including changes in government reimbursement procedures, dependence upon third-party vendors, timing of regulatory approvals, and other risks discussed in the Company's periodic and other filings with the
CONTACT: Stereotaxis Contact:Martin Stammer Chief Financial Officer 314-678-6155Todd Kehrli /Jim Byers MKR Group, Inc. 323-468-2300 stxs@mkr-group.com